What process attributes of clinical genetics services could maximise patient benefits?
about
A blueprint for genomic nursing scienceStakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocolEmpowerment: qualitative underpinning of a new clinical genetics-specific patient-reported outcomeLynch syndrome: barriers to and facilitators of screening and disease managementA primary care specialist genetics service: a cluster-randomised factorial trial.Communicating microarray results of uncertain clinical significance in consultation summary letters and implications for practice.Roles of genetic counselors in South Africa.Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.Valuing Preferences for the Process and Outcomes of Clinical Genetics Services: A Pilot Study.Recontacting in clinical practice: the views and expectations of patients in the United Kingdom.Identifying outcomes of clinical genetic services: qualitative evidence and methodological considerations.Fair allocation of health-care resources: finding a model that does not disenfranchise users of genetic services. A commentary on Rogowski et al....What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective.Valuing the economic benefits of complex interventions: when maximising health is not sufficient.The perceived impact of the European registration system for genetic counsellors and nurses.Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.Complementarity between medical geneticists and genetic counsellors: its added value in genetic services in Europe.The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services.Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care.Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.
P2860
Q30414588-57DD4CA5-B8C7-467C-963F-8E3CDB8B9065Q30602011-9892BCDD-A4B2-4990-8B37-85744DC45BFBQ34493390-BBE6EF93-62B4-4EB5-9DCF-C378F7F040A4Q35233167-DD89E22A-EABB-43B0-AEE7-36D22D732257Q35788703-E6C731F5-765D-41CB-8518-324FCBF3C5CDQ38795003-A85EC95C-162B-49DD-9C52-F340A7DF00EEQ39410098-96A9AB0C-C0A4-472C-A58C-3D32FA5D1B80Q39620236-9A6AC3FB-6141-4C7E-83DF-672DBB4A30D9Q40825708-AE1940E7-C3DE-4A2C-A451-A603017A075AQ41640975-9CCDA06C-D87D-4BD0-B9D8-481107A75063Q42618233-73007ACA-5DC5-4B1E-875F-6EBFB840320EQ42790213-DFA99569-1EFC-469D-A822-1F0B8DEBDCDBQ45291281-F63F635E-6779-4543-9836-48807871B612Q46601983-B21DB8FF-6D15-424E-98C2-71B71A151749Q47342610-28D6DED5-4403-42EF-BE09-48CE8E8E7BC2Q47632310-9402BDCC-4E0B-40BD-AC1B-F2961D78ADA0Q48132549-5AE66376-5376-4A3D-BFE7-2A2C2A21F9C2Q48925587-D8AD77EF-7B63-42A9-B3E2-986DF18550C5Q50903376-EF022668-600F-4C44-92D7-80F69BC00FF6Q52571633-9C6A6CCA-67F1-4A7C-9C71-4CC1330C7237
P2860
What process attributes of clinical genetics services could maximise patient benefits?
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
What process attributes of clinical genetics services could maximise patient benefits?
@ast
What process attributes of clinical genetics services could maximise patient benefits?
@en
type
label
What process attributes of clinical genetics services could maximise patient benefits?
@ast
What process attributes of clinical genetics services could maximise patient benefits?
@en
prefLabel
What process attributes of clinical genetics services could maximise patient benefits?
@ast
What process attributes of clinical genetics services could maximise patient benefits?
@en
P2860
P50
P356
P1476
What process attributes of clinical genetics services could maximise patient benefits?
@en
P2093
Dian Donnai
Rhona Macleod
P2860
P2888
P304
P356
10.1038/EJHG.2008.121
P577
2008-07-02T00:00:00Z